Jenesis Awards Program™
Martine and Bina Rothblatt founded United Therapeutics Corporation when their daughter Jenesis was diagnosed with pulmonary arterial hypertension (PAH).
Faced with a stunning lack of information, support, and treatment options, they became committed to providing better therapies, with the goal of finding a cure for this disease.
Jenesis and her story remain the inspiration behind United Therapeutics and the motivation for the Jenesis Awards Program. The Jenesis Awards Program is designed to recognize and award junior investigators dedicated to medical advancement for pulmonary hypertension through independent clinical, preclinical, and outcomes-based research.
The Jenesis Awards: Catalyzing Change (PDF)
Program Timeline
- November 25, 2024 Application Website Opening
- March 3, 2025 Application Deadline
- April 2025 Applicant Notification
- October 2025 Award Disbursement
Visit
utjenesisawards.com
to submit an application or nomination.
For questions, please email
utjenesisawards@j-jhealth.com
or call 1-516-287-5015.
Statement of Purpose
The Jenesis Innovative Research Awards provide support to US- or Canada-based investigators who are engaged in innovative research that will advance scientific knowledge and enhance patient care in pulmonary hypertension (PH), idiopathic pulmonary fibrosis (IPF), and lung transplantation. The program encourages submissions exploring topics in health equity, determinants of health, and marginalized populations. These awards are intended for junior faculty who are in the early stages of their career. Applicants must be part of an appropriate research group and under the supervision of a qualified mentor. Three awards of up to $100,000 each are issued annually.
The Jenesis Trailblazer Awards recognize exceptional US- or Canada-based women researchers or clinicians who have completed innovative research in the fields of PH, IPF, and lung transplantation. These awards aim to acknowledge and celebrate the development of women leaders as well as to feed the talent pipeline by recognizing women at critical points in their careers. Nominate an outstanding colleague, mentor, or mentee. Two non-monetary awards are issued annually.
Therapeutic Areas of Focus
- Pulmonary Hypertension (PH)
- Idiopathic Pulmonary Fibrosis (IPF)
- Lung Transplantation
Award Categories
Jenesis Innovative Research Awards
Jenesis Clinical Investigations and Outcomes Award™
The Jenesis Clinical Investigations and Outcomes Award™ supports investigators exploring populations with unmet needs or novel treatment approaches. This also includes investigators exploring the science of clinical or patient–reported outcomes research.
Jenesis Pre-Clinical Award™
The Jenesis Pre-Clinical Award™ supports investigators advancing our understanding of disease mechanisms and in the development of novel therapeutic strategies.
Jenesis Determinants of Health Award™
The Jenesis Determinants of Health Award™ supports investigators exploring health equity and outcomes gaps among marginalized communities.
Jenesis Trailblazer Awards
Jenesis Trailblazer Award™
The Jenesis Trailblazer Award™ provides recognition to exceptional and distinguished female researchers. At the time of nomination, nominees must hold the title of either Associate Professor or Professor.
Jenesis Emerging Trailblazer Award™
The Jenesis Emerging Trailblazer Award™ provides recognition to exceptional female researchers who are in the early stages of their career. At the time of nomination, nominees must hold a title of no higher rank than Assistant Professor. Fellows and instructors are eligible.
Scientific Review Committee
Chair
Mardi Gomberg-Maitland, MD, MSc
Walter G. Ross Professor of Clinical Research
Professor of Medicine, Division of Cardiology
Medical Director of MFA/GWUH Pulmonary Hypertension Program
Chief Clinical Research Officer, SMHS OCR
GWU School of Medicine and Health Sciences
George Washington University
Washington, DC
Chair Elect
Stephen Chan, MD, PhD, FAHA
Vitalant Chair in Vascular Medicine
Professor of Medicine, Division of Cardiology
Director, Vascular Medicine Institute
Director, Center for Pulmonary Vascular Biology and Medicine
Associate Chief of Cardiology, Basic Science
University of Pittsburgh School of Medicine and UPMC
Pittsburgh, PA
Review Committee
Professor, Cardiac Surgery
Director, Aortic Surgery
Staff Physician, Smidt Heart Institute
Department of Cardiac Surgery
Cedars Sinai
Los Angeles, CA
Professor of Medicine
Division of Pulmonary and Critical Care Medicine
Director, Pulmonary Hypertension Care Center
Director, Hereditary Hemorrhagic Telangiectasia Center
Washington University in St. Louis
St. Louis, MO
Associate Dean of MD Admissions, Stanford School of Medicine
Professor of Medicine with Tenure
Co-Director, Stanford Translational Investigator Program
(TIP)
Division of Pulmonary, Allergy and Critical Care Medicine
Stanford University Medical Center
Stanford, CA
Clinical Professor of Medicine
Pulmonary and Critical Care Medicine
Lung Transplantation
Stanford Medicine
Director, Lung Transplant Outreach
Stanford, CA
Professor of Medicine
Senior Associate Dean for Precision Medicine
Executive Co-Director, Institute for Health Computing
Director, Pulmonary Hypertension Center
University of Maryland
Baltimore, MD
The Jack B. Lally Endowed Chair in Thoracic Surgery
Director, Lung and Heart-Lung Transplant Program
Director, Ex Vivo Lung Perfusion Program
Surgical Director, Respiratory ECMO Program
Cleveland Clinic
Cleveland, OH
Assistant Dean of Faculty Affairs
Vice Chair of Diversity, Equity, Inclusion
Clinical Professor
Director, Pulmonary Hypertension
Medical Director, Clinical Trial Unit
Department of Internal Medicine
University of New Mexico School of Medicine
Albuquerque, NM
Dudley F. Rochester Professor of Medicine
Chief, Division of Pulmonary and Critical Care Medicine
University of Virginia
Charlottesville, VA
Associate Professor, Department of Medicine
Director, Interstitial Lung Disease Program
Division of Pulmonary, Critical Care & Sleep Medicine
National Jewish Health
Denver, CO
Jenesis Innovative Research Awards Recipients
2024
National Institutes of Health, Bethesda, MD
Category: Clinical Investigations and Outcomes
Risk Stratification of De Novo Donor-Specific Antibodies in Lung Transplant Patients Using Tissue-Specific Cell-Free DNA
Indiana University, Indianapolis, IN
Category: Social Determinants of Health
Race, Ethnicity, Social Deprivation, Social Determinants of Health and Allostatic Load in Patients with Pulmonary Hypertension
University of Pittsburgh, Pittsburgh, PA
Category: Pre-Clinical
Epidemiologic and Mechanistic Links Between Circadian Chronotype and Pulmonary Hypertension”
2023
University of Pennsylvania
Category: Clinical Investigations and Outcomes
Frailty and Physical Activity in Pulmonary Arterial Hypertension
Indiana University
Category: Pre-Clinical
Targeting the Stratifin Mediated Enothelial-Pericyte Crosstalk in Pulmonary Hypertension
University of Pittsburgh
Category: Pre-Clinical
2022
Vanderbilt University Medical Center, Nashville, TN
Category: Pre-Clinical
Harnessing Genetics for Novel Therapeutic Targets in Pulmonary Hypertension due to Heart Failure
University of California, San Francisco
Category: Pre-Clinical
Role of Classical Monocytes in Hypoxic Pulmonary Hypertension
Boston University School of Medicine, Boston, MA
Category: Clinical Investigations and Outcomes
Biomarkers of Left Ventricular Strain in Systemic Sclerosis-Related Pulmonary Hypertension
Mayo Clinic, Rochester, MN
Category: Clinical Investigations and Outcomes
Comprehensive O2 Transfer Analysis from the Lung to Mitochon- dria with Inhaled Treprostinil in ILD Pulmonary Hypertension
2020 - 2021
University of Pittsburgh
Category: Pre-Clinical
CX3CR1 Triggers Neutrophil Recruitment to the Lungs and Enhances Smooth Muscle Cell Proliferation in Pulmonary Hypertension
University of Rochester, Medical Center, Rochester, NY
Category: Clinical Investigations and Outcomes
Cardiac Expenditure Correlates With Right Ventricular Function Measured by Cardiac MRI
2019
University of Rochester Medical Center, Rochester, NY
Category: Pre-Clinical
Modulation of TNF-alpha as Cause and Treatment of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
University of Minnesota, Minneapolis
Category: Pre-Clinical
Protein O-GlcNACylation in RV Failure
University of Washington, Seattle
Category: Pre-Clinical
Establishing Patient-Specific Microvessel Models of Pulmonary Arterial Hypertension
2018
University of Wisconsin, Madison*
Category: Clinical Investigations and Outcomes
Cardiac Metabolic Remodeling After Pulmonary Vasodilator Therapy in Pulmonary Arterial Hypertension: A Pilot Study
Indiana University School of Medicine, Indianapolis
Category: Pre-Clinical
Mechanistic Role of Skeletal Muscle SIRT3 in Parenteral Treprostinil-Mediated Improvement of Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction
The Warren Alpert Medical School of Brown University Brown University, Providence
Category: Clinical Investigations and Outcomes
Health-Related Quality of Life: Patient-Focused Strategies for Measuring and Improving Sexual Health and Functioning Among Patients with Pulmonary Arterial Hypertension
* at time of award
Jenesis Trailblazer Awards Recipients
2024
Professor and Program Director
Category: Trailblazer
Division of Cardiothoracic Surgery University of California, San Diego La Jolla, CA
Assistant Professor of Medicine
Category: Emerging Trailblazer
Weill Cornel Medicine Division of Pulmonary and Critical Care Medicine New York, NY
2023
Professor of Medicine
Category: Trailblazer
R.H. and Jane G. Logan Endowed Chair in Cardiology Founder of the UCSF Adult PH Comprehensive Care Center Medical Director of Heart Transplantation University of California San Francisco San Francisco, CA
Associate Professor of Medicine and Pediatrics
Category: Emerging Trailblazer
UT Southwestern Dallas, TX
Assistant Professor of Pediatrics
Category: Emerging Trailblazer
Boston Children’s Hospital Harvard Medical School Boston, MA
2022
Professor of Pediatrics (in Medicine)
Category: Trailblazer
Director, Adult and Pediatric Pulmonary Hypertension Comprehensive Care Center and CTEPH Program Director, PPHNet Vice Chair for Clinical and Translational Research, Department of Pediatrics Columbia University Irving Medical Center – New York Presbyterian New York, NY
Have a question?
Medical affairs professionals are available to help with questions regarding UT products.
Call us at: 1-877-522-2950
To report suspected adverse reactions contact United
Therapeutics
1-866-458-6479
or FDA at
1-800-FDA-1088 or
www.fda.gov/medwatch
...or submit a request for information.
This form is intended to be used by research and healthcare professionals. If you are not a research or healthcare professional, please click here.